Veristrat as Predictor of Benefit of First Line Non Small Cell Lung Cancer (NSCLC) Patients From Standard Chemotherapy

Clinical trial NCT02055144 · UNKNOWN

Trial details

NCT number: NCT02055144
Sponsor: IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Status: UNKNOWN
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer

Start date: 2011-02-01
Primary completion: 2017-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.